⌘K
Loading ticker…
As of 2026-08-24, Ingevity Corporation (NGVT) has a 3-month relative strength percentile of 55 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.9%, relative volume 0.86×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
NGVT appears in 1 ETF as of Jun 2026: PSC at 0.14% weight, $3M notional.
Held by 93 ETFs · $660M across latest filings · largest weight 3.87% (TINT).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| PSC | 0.14% | $3M | −0.02 pp |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NGVT Jan avg: 7.94% median: 11.23% win: 75% σ: 10.81% n: 4 2022-04-12 → 2026-07-31 | NGVT Feb avg: 4.90% median: 4.98% win: 100% σ: 3.82% n: 4 2022-04-12 → 2026-07-31 | NGVT Mar avg: -6.75% median: -7.24% win: 25% σ: 10.07% n: 4 2022-04-12 → 2026-07-31 | NGVT Apr avg: -0.98% median: 0.31% win: 60% σ: 9.77% n: 5 2022-04-12 → 2026-07-31 | NGVT May avg: -1.58% median: -4.48% win: 40% σ: 23.52% n: 5 2022-04-12 → 2026-07-31 | NGVT Jun avg: 3.52% median: 4.16% win: 60% σ: 14.11% n: 5 2022-04-12 → 2026-07-31 | NGVT Jul avg: 3.25% median: 4.99% win: 60% σ: 5.62% n: 5 2022-04-12 → 2026-07-31 | NGVT Aug avg: 3.64% median: -4.66% win: 50% σ: 25.73% n: 4 2022-04-12 → 2026-07-31 (current) | NGVT Sep avg: -8.00% median: -8.56% win: 0% σ: 5.63% n: 4 2022-04-12 → 2026-07-31 | NGVT Oct avg: 0.01% median: 2.25% win: 50% σ: 11.77% n: 4 2022-04-12 → 2026-07-31 | NGVT Nov avg: 6.53% median: 6.73% win: 50% σ: 11.28% n: 4 2022-04-12 → 2026-07-31 | NGVT Dec avg: 2.23% median: 1.65% win: 50% σ: 18.15% n: 4 2022-04-12 → 2026-07-31 |